Magnitude of the Placebo Response Across Treatment Modalities Used for Treatment-Resistant Depression in Adults
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Magnitude of the Placebo Response Across Treatment Modalities Used for Treatment-Resistant Depression in Adults
Authors
Keywords
-
Journal
JAMA Network Open
Volume 4, Issue 9, Pages e2125531
Publisher
American Medical Association (AMA)
Online
2021-09-25
DOI
10.1001/jamanetworkopen.2021.25531
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Determinants of sham response in tDCS depression trials: A systematic review and meta-analysis
- (2021) Stefanie De Smet et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Comparative efficacy and acceptability of neuromodulation procedures in the treatment of treatment-resistant depression: a network meta-analysis of randomized controlled trials
- (2021) Hao Li et al. JOURNAL OF AFFECTIVE DISORDERS
- Protocol for a systematic review and meta-analysis of the placebo response in treatment-resistant depression: comparison of multiple treatment modalities
- (2021) Brett D M Jones et al. BMJ Open
- Medical practice and placebo response: an inseparable bond?
- (2020) Sandra Jilch et al. WIENER KLINISCHE WOCHENSCHRIFT
- A randomized controlled trial of a standard 4-week protocol of repetitive transcranial magnetic stimulation in severe treatment resistant depression
- (2020) P.F.P. van Eijndhoven et al. JOURNAL OF AFFECTIVE DISORDERS
- A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 – January 2019
- (2020) Walter S. Marcantoni et al. JOURNAL OF AFFECTIVE DISORDERS
- Superolateral medial forebrain bundle deep brain stimulation in major depression: a gateway trial
- (2019) Volker A. Coenen et al. NEUROPSYCHOPHARMACOLOGY
- Antidepressant and antisuicidal effects of ketamine on the functional connectivity of prefrontal cortex-related circuits in treatment-resistant depression: A double-blind, placebo-controlled, randomized, longitudinal resting fMRI study
- (2019) Mu-Hong Chen et al. JOURNAL OF AFFECTIVE DISORDERS
- Early score fluctuation and placebo response in a study of major depressive disorder
- (2019) Steven D. Targum et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study
- (2018) Mary Hobart et al. CURRENT MEDICAL RESEARCH AND OPINION
- The burden of treatment-resistant depression: a systematic review of the economic and quality of life literature
- (2018) Karissa Johnston et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy and acceptability of non-invasive brain stimulation for the treatment of adult unipolar and bipolar depression: A systematic review and meta-analysis of randomised sham-controlled trials
- (2018) Julian Mutz et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- A systematic review and meta-analysis on placebo response to repetitive transcranial magnetic stimulation for depression trials
- (2018) Laís B. Razza et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
- (2018) Fernanda Palhano-Fontes et al. PSYCHOLOGICAL MEDICINE
- Predictors of Placebo Response in Pharmacological Clinical Trials of Negative Symptoms in Schizophrenia: A Meta-regression Analysis
- (2018) David Fraguas et al. SCHIZOPHRENIA BULLETIN
- Effect of Repetitive Transcranial Magnetic Stimulation on Treatment-Resistant Major Depression in US Veterans
- (2018) Jerome A. Yesavage et al. JAMA Psychiatry
- A randomised, placebo-controlled 24-week study evaluating adjunctive brexpiprazole in patients with major depressive disorder
- (2018) Michael Bauer et al. ACTA NEUROPSYCHIATRICA
- Efficacy of adjunctive low-dose cariprazine in major depressive disorder
- (2018) Maurizio Fava et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Repeat-Dose Ketamine Augmentation for Treatment-Resistant Depression with Chronic Suicidal Ideation: A Randomized, Double Blind, Placebo Controlled Trial
- (2018) Dawn F. Ionescu et al. JOURNAL OF AFFECTIVE DISORDERS
- Unknown
- (2018) PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Cognitive behavioral therapy for treatment-resistant depression: A systematic review and meta-analysis
- (2018) Jia-Mei Li et al. PSYCHIATRY RESEARCH
- Placebo and nocebo reactions in randomized trials of pharmacological treatments for persistent depressive disorder. A meta-regression analysis
- (2017) Ramona Meister et al. JOURNAL OF AFFECTIVE DISORDERS
- Two Versus One High-Frequency Repetitive Transcranial Magnetic Stimulation Session per Day for Treatment-Resistant Depression
- (2017) Christos Theleritis et al. JOURNAL OF ECT
- Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial
- (2017) Muhammad I Husain et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
- (2017) Tung-Ping Su et al. NEUROPSYCHOPHARMACOLOGY
- Unknown
- (2017) World Psychiatry
- Unilateral and bilateral MRI-targeted repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled study
- (2016) Daniel M. Blumberger et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants
- (2016) Robert M. Berman et al. CNS SPECTRUMS
- A Randomized Sham-Controlled Trial of Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Chronic Treatment-Resistant Depression
- (2015) Darin D. Dougherty et al. BIOLOGICAL PSYCHIATRY
- Pilot study of feasibility of the effect of treatment with tDCS in patients suffering from treatment-resistant depression treated with escitalopram
- (2015) D. Bennabi et al. CLINICAL NEUROPHYSIOLOGY
- From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings
- (2015) Konstantinos N. Fountoulakis et al. Current Neuropharmacology
- Predictors of placebo response in bipolar depression
- (2015) Andrew A. Nierenberg et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: A six-month clinical follow-up study
- (2015) Carmen Concerto et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants
- (2015) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder
- (2015) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of the Augmentation of a Nicotinic Acetylcholine Receptor Partial Agonist in Depression
- (2015) Maurizio Fava et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- CONSORT extension for reporting N-of-1 trials (CENT) 2015: Explanation and elaboration
- (2015) L. Shamseer et al. BMJ-British Medical Journal
- CONSORT extension for reporting N-of-1 trials (CENT) 2015: Explanation and elaboration
- (2015) L. Shamseer et al. BMJ-British Medical Journal
- Efficacy of prefrontal theta-burst stimulation in refractory depression: a randomized sham-controlled study
- (2014) Cheng-Ta Li et al. BRAIN
- Aripiprazole augmentation to antidepressant therapy in Japanese patients with major depressive disorder: A randomized, double-blind, placebo-controlled study (ADMIRE study)
- (2013) Kunitoshi Kamijima et al. JOURNAL OF AFFECTIVE DISORDERS
- Intensive HF-rTMS treatment in refractory medication-resistant unipolar depressed patients
- (2013) Chris Baeken et al. JOURNAL OF AFFECTIVE DISORDERS
- Less Is More in Antidepressant Clinical Trials
- (2013) Bret R. Rutherford et al. JOURNAL OF CLINICAL PSYCHIATRY
- Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression
- (2013) Shao-Tsu Chen et al. Neuropsychiatric Disease and Treatment
- A randomized add-on trial of high-dose d-cycloserine for treatment-resistant depression
- (2012) Uriel Heresco-Levy et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A double blind randomized trial of unilateral left and bilateral prefrontal cortex transcranial magnetic stimulation in treatment resistant major depression
- (2012) Paul B. Fitzgerald et al. JOURNAL OF AFFECTIVE DISORDERS
- Does the Presence of an Open-Label Antidepressant Treatment Period Influence Study Outcome in Clinical Trials Examining Augmentation/Combination Strategies in Treatment Partial Responders/Nonresponders With Major Depressive Disorder?
- (2012) Nadia Iovieno et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Combination of Antidepressant Drug Therapy and High-Frequency Repetitive Transcranial Magnetic Stimulation in Medication-Resistant Depression
- (2012) Bahadir Bakim et al. KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
- A Randomized Double-Blind Sham-Controlled Study of Transcranial Direct Current Stimulation for Treatment-Resistant Major Depression
- (2012) Daniel M. Blumberger et al. Frontiers in Psychiatry
- Transcranial direct current stimulation in treatment resistant depression: A randomized double-blind, placebo-controlled study
- (2011) U. Palm et al. Brain Stimulation
- A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression
- (2011) James G. Barbee et al. JOURNAL OF CLINICAL PSYCHIATRY
- A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression
- (2011) Daniel M. Blumberger et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Daily Left Prefrontal Transcranial Magnetic Stimulation Therapy for Major Depressive Disorder
- (2010) Mark S. George et al. ARCHIVES OF GENERAL PSYCHIATRY
- Why Has the Antidepressant-Placebo Difference in Antidepressant Clinical Trials Diminished over the Past Three Decades?
- (2010) Arif Khan et al. CNS Neuroscience & Therapeutics
- Does Inclusion of a Placebo Arm Influence Response to Active Antidepressant Treatment in Randomized Controlled Trials?
- (2010) Mark Sinyor et al. JOURNAL OF CLINICAL PSYCHIATRY
- Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression?
- (2010) S. Pallanti et al. NEUROSCIENCE
- High-frequency rTMS treatment increases left prefrontal myo-inositol in young patients with treatment-resistant depression
- (2010) Huirong Zheng et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Right and left dorsolateral pre-frontal rTMS treatment of refractory depression: A randomized, sham-controlled trial
- (2010) William J. Triggs et al. PSYCHIATRY RESEARCH
- Meta-analysis of the placebo response in antidepressant trials
- (2009) Winfried Rief et al. JOURNAL OF AFFECTIVE DISORDERS
- The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder
- (2009) Ronald N. Marcus et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Placebo Response of Non-Pharmacological and Pharmacological Trials in Major Depression: A Systematic Review and Meta-Analysis
- (2009) André Russowsky Brunoni et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More